Catherine Ramsey
Stock Analyst at Baird
(3.29)
# 988
Out of 5,172 analysts
56
Total ratings
39.53%
Success rate
7.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $239 → $257 | $195.28 | +31.61% | 7 | Feb 27, 2026 | |
| CSTL Castle Biosciences | Maintains: Outperform | $41 → $44 | $25.00 | +76.00% | 10 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $124.33 | -12.33% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $85.94 | +43.12% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $298.99 | +17.73% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $42.07 | +4.59% | 7 | May 6, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $474.39 | +40.18% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $111.30 | +43.76% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $104.91 | -28.51% | 1 | Aug 3, 2022 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $195.28
Upside: +31.61%
Castle Biosciences
Feb 27, 2026
Maintains: Outperform
Price Target: $41 → $44
Current: $25.00
Upside: +76.00%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $124.33
Upside: -12.33%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $85.94
Upside: +43.12%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $298.99
Upside: +17.73%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $42.07
Upside: +4.59%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $474.39
Upside: +40.18%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $111.30
Upside: +43.76%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $104.91
Upside: -28.51%